Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

Marie Robin,Raphaël Porcher,W Zinke-Cerwenka,A. van Biezen,Liisa Volin,Ghulam J. Mufti,Charles Craddock,J. Finke,Carlos Richard,J Passweg,Andrew Peniket,Johan Maertens,Gülsan Türköz Sucak,Tobias Gedde-Dahl,A. Vitek,A. Nagler,D. Blaise,D. Beelen,N Maillard,Rainer Schwerdtfeger,T.J.M. de Witte,N. Kröger

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

2017

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

Keywords:

Diabetes mellitus
Progenitor cell
Immunology
Graft-versus-host disease
Lower risk
Medicine
Stem cell
Transplantation
Malignancy
Haematopoiesis
International Prognostic Scoring System
Bone marrow
Hazard ratio

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations